• 1. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 2. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 3. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester (CAS No. 151831-22-0): A Comprehensive Overview

The compound Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester, identified by the CAS number 151831-22-0, represents a significant molecule in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic compound belongs to the pyrazolopyridine class, a scaffold that has garnered considerable attention due to its versatile biological activities and structural potential for drug development.

Pyrazolopyridines are a class of nitrogen-containing heterocycles that exhibit a broad spectrum of pharmacological properties. The structural motif of Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester combines the functionalities of a pyrazole ring fused with a pyridine ring, further modified by a formyl group at the 3-position and an ethyl ester at the 2-position. This specific arrangement confers unique reactivity and binding capabilities, making it a valuable intermediate in synthetic chemistry and a promising candidate for further derivatization.

The< strong>formyl group at the 3-position of the pyrazolopyridine core is particularly noteworthy, as it serves as a reactive handle for further chemical modifications. This functionality allows for condensation reactions with various nucleophiles, enabling the introduction of diverse substituents that can modulate the biological activity of the molecule. In particular, formyl groups are frequently utilized in the synthesis of bioactive compounds due to their ability to participate in Schiff base formation, leading to imine derivatives that exhibit enhanced binding affinity to biological targets.

The< strong>ethyl ester moiety at the 2-position adds another layer of complexity to the compound's reactivity. Ester groups are known to be labile under various conditions, allowing for hydrolysis or transesterification reactions that can be exploited in synthetic pathways. This flexibility makes Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester a versatile building block for designing novel derivatives with tailored pharmacological properties.

In recent years, there has been growing interest in exploring the therapeutic potential of pyrazolopyridines. Several studies have highlighted their efficacy in modulating various biological pathways, including enzyme inhibition and receptor binding. The< strong>formyl group and< strong>ethyl ester functionalities in this compound provide multiple opportunities for structural optimization and lead discovery. For instance, recent research has demonstrated that derivatives of pyrazolopyridines can exhibit potent antitumor activity by inhibiting key signaling pathways involved in cancer cell proliferation and survival.

The synthesis of< strong>Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester involves multi-step organic transformations that highlight its synthetic accessibility. The process typically begins with the condensation of appropriate precursors to form the pyrazolopyridine core, followed by functionalization at the 3-position with a formyl group. Subsequent esterification at the 2-position completes the synthesis. Advances in synthetic methodologies have enabled more efficient and scalable production methods for this compound, facilitating its use in both academic research and industrial applications.

The< strong>Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester (CAS No. 151831-22-0) has found applications in various areas of medicinal chemistry. Its ability to serve as a versatile intermediate allows for the rapid construction of libraries of derivatives for high-throughput screening (HTS). This approach has been successfully employed in identifying novel compounds with therapeutic potential against diverse diseases.

In addition to its role as a synthetic intermediate, this compound has also been investigated for its potential biological activities. Preliminary studies suggest that derivatives of< strong>Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester may exhibit antimicrobial properties by interfering with essential bacterial metabolic pathways. The< strong>formyl group, in particular, has been shown to interact with biological targets in ways that disrupt microbial viability.

The structural features of< strong>Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester, including its nitrogen-rich heterocyclic core and functionalized side chains, make it an attractive scaffold for drug discovery efforts. The compound's ability to undergo further chemical modifications allows researchers to fine-tune its pharmacological properties for specific therapeutic applications. This flexibility is particularly valuable in developing targeted therapies where precise molecular interactions are critical.

In conclusion,< strong>Pyrazolo[1,5-a]pyridine-2-carboxylic acid, 3-formyl-, ethyl ester, CAS No.< strong>151831-22-0, is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features and reactivity make it a valuable tool for synthesizing novel bioactive molecules. As ongoing research continues to uncover new applications for this compound and its derivatives, it is likely to remain an important player in drug discovery efforts aimed at addressing various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)